|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1992-1-21
|
|
pubmed:abstractText |
Numerous reports suggest that allogeneic bone marrow transplantation prolongs the survival of adult patients with acute myelogenous leukemia (AML) in first remission. However, it is unclear how many such patients actually undergo this procedure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
16
|
|
pubmed:volume |
326
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
156-60
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:1727546-Adult,
pubmed-meshheading:1727546-Age Factors,
pubmed-meshheading:1727546-Bone Marrow Transplantation,
pubmed-meshheading:1727546-HLA Antigens,
pubmed-meshheading:1727546-Histocompatibility Testing,
pubmed-meshheading:1727546-Humans,
pubmed-meshheading:1727546-Leukemia, Myeloid, Acute,
pubmed-meshheading:1727546-Remission Induction,
pubmed-meshheading:1727546-Transplantation, Homologous
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation.
|
|
pubmed:affiliation |
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York 10021.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
